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0929-6646/Copyright ª 2015, FormosaBackground/Purpose: Fluid overload is associated with acute kidney injury (AKI) and mortality.
There is no convenient precise method to guide fluid therapy in critically ill patients. We aimed
to investigate whether brain natriuretic peptide (BNP) can predict the renal outcome and mor-
tality of critically ill patients and be used to guide fluid management.
Methods: This prospective observational study included patients who were admitted to the
intensive care unit (ICU). Patients with underlying heart disease and heart dysfunction were
excluded. Plasma BNP levels were obtained on admission (D0), at 24 hours (D1), and at 48 hours
(D2). The primary outcome was AKI development during the ICU stay and recovery of AKI at ICU
discharge. The secondary outcome was in-ICU mortality.
Results: One hundred and sixty-three patients were enrolled for analysis. The delta-BNP level
within the initial 24 hours after ICU admission rather than fluid accumulation was significantly
correlated with delta-central venous pressure levels (rZ 0.219, pZ 0.010). Delta-Brain natri-
uretic peptide levels of < 81.8% within the initial 24 hours was an independent predictor of
better renal outcome (i.e., no AKI or AKI with recovery). The increment in the BNP level from
D0 to D1 was also a significant risk factor of mortality. In the a priori subgroup analysis forave no conflicts of interest relevant to this article.
on, Department of Internal Medicine, National Taiwan University Hospital, Number 7, Chung Shan
.tw (Y.-M. Chen).
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1188 Y.-H. Chou et al.patients with sepsis, delta-BNP levels from D0 to D1 remained a significant predictor of renal
outcome and mortality.
Conclusion: Our study showed that delta-BNP levels within 24 hours of admission to the ICU are
better than fluid accumulation as a predictor of AKI, recovery, and mortality.
Copyright ª 2015, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Acute kidney injury (AKI) is a common complication of pa-
tients in an intensive care unit (ICU), and it is an inde-
pendent predictor of outcome.1,2 Many investigators have
reported that fluid overload results in poor renal outcomes
and higher mortality in critically ill patients with AKI.3e6
Patients in shock need intensive hydration to restore he-
modynamic stability and renal blood flow; however, too
much fluid damages internal organs, including the kidney.7
Therefore, to prevent AKI and to enhance recovery, a fast,
simple, and cost-effective method is needed that can pre-
dict renal outcome and precisely guide fluid therapy, which
involves initial volume resuscitation, subsequent serial fluid
status assessment for fluid balance, and appropriate timing
of fluid removal.8 However, various traditional methods
used to guide fluid therapy are invasive and inconvenient.9
Brain natriuretic peptide (BNP) is a biomarker that can
be easily obtained. It is a plasma neurohormone produced
primarily by ventricular myocardiocytes in response to
myocardial stretching and volume overload.10 Brain natri-
uretic peptide has been used to guide fluid management in
patients with heart failure and in patients on hemodialysis.
Furthermore, many investigators have reported an associ-
ation between the absolute BNP level and mortality in
critically ill patients.11,12 Therefore, our hypothesis was
that the BNP level could also predict renal outcome and it
has the potential to be a convenient cost-effective marker
for fluid management in critically ill patients. The first aim
of our study was to specify the association between the
delta-BNP level and patient outcomes (i.e., AKI occurrence,
recovery, and mortality). The second aim was to evaluate
which range of delta-BNP levels is suitable for critical pa-
tients to avoid poor renal outcome induced by fluid
overload.Methods
Study population and protocol
This prospective observational study was approved by the
Institutional Review Board of the National Taiwan Univer-
sity Hospital (Taipei, Taiwan; approval number
201111012RIB). All participants or their legal representa-
tives provided written informed consent. This study was
performed in compliance with the declaration of Helsinki.
We included 163 patients in the final analysis, after
consecutively selecting patients who were older than 18
years and admitted to the ICU of a university hospital be-
tween April 2012 and June 2014 (Figure 1). To avoid theeffects of other causes of chronic or severe heart dysfunc-
tion on the BNP level, the study investigators excluded pa-
tients with chronic heart disease (based on chart reviews),
with an abnormal echocardiogram on admission (i.e., sys-
tolic dysfunction: left ventricular ejection fraction < 55%;
diastolic dysfunction: E wave/A wave ratio < 0.75 or > 1.5),
acute coronary syndrome, acute myocardial infarction,
acute pulmonary embolism, status post cardiopulmonary
resuscitation, cor pulmonale, and respiratory failure with
high positive end-expiratory pressure (> 10 cmH2O). Plasma
BNP levels were obtained on ICU admission [i.e., Day
0 (D0)], at 24 hours [i.e., Day 1 (D1)], and at 48 hours [i.e.,
Day 2 (D2)]. Plasma BNP samples were separated from the
cells immediately, stored at 4C, and measured within 4
hours using an automated microparticle enzyme immuno-
assay (AxSYM; Abbott, Park, Illinois, USA).13 The intensive
care specialists were blinded to the BNP levels.
The primary outcome was AKI development during the
ICU stay and recovery of AKI at ICU discharge. The sec-
ondary outcome was in-ICU mortality. On ICU admission or
during the ICU stay, AKI was diagnosed when a patient had
an incremental increase in serum creatinine of > 0.3 mg/dL
within 48 hours or an increase of at least 50% from the
baseline within 7 days or a urine output of < 0.5 mL/kg/h
for > 6 hours.14 Acute kidney injury recovery was defined as
a decrease in the serum creatinine level at ICU discharge by
at least 50% from the peak value. The patients were divided
into the group with better renal outcome (i.e., no AKI or AKI
with recovery during the ICU stay) and the group with worse
renal outcome (i.e., AKI without recovery during the ICU
stay). The study investigators also classified the causes of
the ICU admission and AKI.
Data collection
All data were prospectively collected. Demographic data,
comorbid diseases, severity scores such as the Glasgow
Coma Scale score, the Acute Physiology and Chronic Health
Evaluation II (APACHE II) score, and the Sequential Organ
Failure Assessment (SOFA) score were determined at ICU
admission. Blood chemistry and clinical parameters were
measured before and after the ICU stay. The patients’ body
weight, and fluid intake and output were obtained daily
during the ICU stay. Fluid accumulation was calculated by
the following formula:
Sdaily [fluid intake (mL)  total output (mL)]. (1)
Chronic kidney disease is defined as an abnormality in
the kidney structure or function that is present for > 3
months.15
Figure 1 Flowchart of the participants in the cohort. AKI Z acute kidney injury; ICU Z intensive care unit.
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The statistical analysis was performed using R 3.1.0 soft-
ware (R Foundation for Statistical Computing, Vienna,
Austria). For statistical testing, two-sided p values of 
0.05 were considered statistically significant. The distri-
butional properties of continuous variables were expressed
by the mean  the standard deviation. Categorical vari-
ables were represented by the frequency and percentage.
In univariate analysis, the two-sample t test, Wilcoxon
rank-sum test (or ManneWhitney U test), and the Chi-
square test were used to examine the differences be-
tween the better and worse renal outcome groups in the
distributions of the continuous variables and categorical
variables. Multivariate analysis was then conducted by
fitting logistic regression models to estimate the effect of
predictors on the binary outcomes.
Basic model-fitting techniques for variable selection,
goodness-of-fit (GOF) assessment, and regression di-
agnostics and remedies were used in the regression ana-
lyses to ensure analytical quality. In particular, the
stepwise variable selection procedure (with iterations be-
tween the forward and backward steps) was applied to
obtain the best candidate final regression model. All uni-
variate significant and nonsignificant relevant covariates
were included in the variable list (Table 1). The significance
levels for entry and staying were set to 0.15 (or larger) to
be conservative. With the aid of substantive knowledge,
the best candidate final regression model was then identi-
fied manually by dropping in covariates with p > 0.05 one ata time until all regression coefficients were significantly
different from 0.
The estimated area under the receiver operating char-
acteristic curve (also called the c statistic), adjusted
generalized R2, and the HosmereLemeshow GOF test were
examined to assess the GOF of the fitted logistic regression
model. An adjusted generalized R2 of  0.30 indicated an
acceptable fit. A c statistic value of  0.7 also indicated an
acceptable level of discrimination power. Larger p values of
the HosmereLemeshow GOF test indicated better fits of
the logistic regression model.
We also used generalized additive models to detect
nonlinear effects of continuous covariates and to identify
appropriate cutoff points for making continuous covariates
discrete, if necessary, during the stepwise variable selec-
tion procedure. We performed a priori subgroup analysis for
patients with sepsis because fluid management of septic
patients is critical. Based on the results of logistic regression
modeling of AKI recovery and mortality, we chose two fluid
status parameters to test their interaction with sepsis in the
regression analysis: (1) the percent change in BNP level from
D0 to D1 and (2) fluid accumulation during the ICU stay.Results
Patients’ characteristics
Most patients were admitted to the ICU because of septic
shock and respiratory failure (Table S1). Sepsis was the
Table 1 The patients’ demographics and clinical characteristics at intensive care unit admission in the AKI without recovery
group and the no AKI or AKI with recovery group.
Variable All
(n Z 163)
AKI
without recovery
(n Z 26)
No AKI (n Z 38) or
AKI with recovery
(n Z 99)
p
Demographics
Age (y) 67.5 ( 13.4) 71.4 ( 12.0) 67.0 ( 13.5) 0.211
Male (%) 106 (65.0) 16 (61.5) 90 (65.7) 0.682
Baseline creatinine (mg/dL) 1.04 ( 0.68) 1.27 ( 1.02) 1.01 ( 0.61) 0.122
Comorbid disease (%)
Diabetes mellitus 68 (41.7) 9 (34.6) 59 (43.1) 0.423
Hypertension 83 (50.9) 14 (53.8) 70 (51.1) 0.851
CKD 19 (11.7) 3 (11.5) 16 (11.7) 0.984
Pulmonary disease 22 (13.5) 5 (19.2) 17 (12.4) 0.351
Liver cirrhosis 20 (12.3) 3 (11.5) 17 (12.4) 0.902
Malignancy 11 (6.7) 5 (19.2) 6 (4.4) < 0.001
CVA 14 (8.6) 2 (7.7) 12 (8.7) 0.861
Clinical parameters on ICU admission
Mean arterial pressure (mmHg) 81.1 ( 19.3) 88.2 ( 23.8) 80.0 ( 18.5) 0.172
Temperature (C) 36.4 ( 1.5) 36.5 ( 1.4) 36.4 ( 1.6) 0.712
Heart rate (bpm) 107.2 ( 21.6) 117.3 ( 19.7) 105.8 ( 21.6) 0.021
Serum creatinine (mg/dL) 2.3 ( 2.0) 3.3 ( 2.6) 2.2 ( 1.8) 0.023
Hemoglobin (g/dL) 11.1 ( 2.5) 10.7 ( 2.5) 11.2 ( 2.5) 0.402
WBC (/mL) 14786.0 ( 9323.8) 10749.5 ( 9247.2) 15354.1 ( 9227.0) 0.011
Serum sodium (mmol/L) 134.6 ( 8.4) 135.5 ( 10.4) 134.5 ( 8.2) 0.732
Serum potassium (mmol/L) 4.0 ( 0.9) 4.0 ( 0.7) 4.0 ( 0.9) 0.902
Serum lactate (mmol/L) 1.1 ( 0.8) 1.4 ( 0.6) 1.1 ( 0.8) 0.014
Serum albumin (g/dL) 3.0 ( 0.6) 3.0 ( 0.6) 3.0 ( 0.6) 0.731
BNP D0 (pg/mL) 749.9 ( 959.9) 963.6 ( 999.4) 719.8 ( 955.2) 0.262
BW D0 (kg) 57.8 ( 13.3) 60.6 ( 13.8) 57.4 ( 13.2) 0.172
CVP level 10.3 ( 6.1) 10.7 ( 4.6) 10.2 ( 6.3) 0.763
APACHE II score 21.2 ( 8.6) 27.4 ( 7.2) 20.3 ( 8.3) <0.001
SOFA score 8.0 ( 3.5) 9.9 ( 2.7) 7.7 ( 3.5) <0.001
GCS score 11.6 ( 3.6) 11.5 ( 2.9) 11.6 ( 2.9) 0.601
ICU course
Peaked serum creatinine of AKI (mg/dL) 3.5 ( 2.5) 2.6 ( 1.8) 0.092
Serum creatinine on ICU discharge (mg/dL) 4.6 ( 0.7) 1.5 ( 1.8) <0.001
BNP D1 (pg/mL) 1033.9 ( 1802.0) 2324.4 ( 4303.9) 852.3 ( 974.8) <0.001
BNP D2 (pg/mL) 973.4 ( 1804.2) 2004.4 ( 4131.7) 828.3 ( 1118.8) 0.012
BW D1 (kg) 59.0 ( 13.0) 62.3 ( 13.9) 58.5 ( 12.9) 0.241
BW D2 (kg) 59.7 ( 12.8) 62.9 ( 14.3) 59.3 ( 12.6) 0.243
Fluid accumulation D1 (mL) 2046.0 ( 2758.2) 2964.7 ( 2589.0) 1916.7 ( 2765.8) 0.122
Fluid accumulation D2 (mL) 2132.1 ( 3291.4) 3254.9 ( 3210.3) 1974.1 ( 3283.6) 0.071
Fluid accumulation during ICU stay (mL) 1934.6 ( 4733.5) 4433.4 ( 4231.7) 1583.0 ( 4708.3) 0.012
Sepsis (%) 119 (73.0) 19 (73.0) 100 (73.0) 0.254
Use of inotropic or vasopressor drugs (%) 111 (68.1) 17 (65.4) 94 (68.6) 0.603
Dialysis (%) 25 (15.3) 8 (30.8) 17 (12.4) <0.001
Mechanical ventilation (%) 26 (16.0) 8 (30.8) 18 (13.1) 0.043
ICU mortality (%) 42 (25.8) 13 (50.0) 29 (21.2) <0.001
ICU stay (d) 7.3 ( 6.9) 10.1 ( 12.6) 6.9 ( 5.7) 0.014
Data are presented as the n (%) or mean ( standard deviation).
AKIZ acute kidney injury; APACHE IIZ Acute Physiology and Chronic Health Evaluation II; BNPZ brain natriuretic peptide; BWZ body
weight; CKD Z chronic kidney disease; GCSZ Glasgow Coma Scale; CVA Z cerebrovascular accident; CVPZ central venous pressure;
ICU Z intensive care unit; SOFA Z Sequential Organ Failure Assessment; WBC Z white blood cell.
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hypovolemic shock was more frequent in the AKI with re-
covery group.
We enrolled 163 patients. Among these patients, the no
AKI or AKI with recovery group accounted for 84.0% ofpatients (Table 1). Compared to the no AKI or AKI with re-
covery group, the AKI without recovery group had a higher
malignancy rate (p < 0.001), higher heart rate (pZ 0.021),
higher serum creatinine level on ICU admission (pZ 0.023),
lower white blood cell count (WBC; p Z 0.011), higher
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lation during their ICU stay (p < 0.001). The plasma BNP
levels on D1 (p < 0.001) and D2 (p < 0.001), APACHE II score
(p< 0.001), SOFA score (p< 0.001), andmortality (p< 0.001)
were also higher in the AKI without recovery group than in
the no AKI or AKI with recovery group (Table 1).
Changes in the BNP level and fluid status
parameters
The delta-BNP levels from D0 to D1, change in body weight
from D0 to D1, fluid accumulation on D1, fluid accumulation
on D2, and fluid accumulation during the entire ICU stay
were lower in the no AKI or AKI with recovery group (Figures
2Ae2E). The delta-BNP level from D0 to D1 was significantly
correlated with the delta-central venous pressure levels
(Figure S1), but there was no correlation between the
delta-BNP level (from D0 to D1) and fluid accumulation on
D1 (Figure 2F).
Among the septic patients, the no AKI or AKI with re-
covery group had lower BNP levels on D0, D1, and D2,
smaller delta-BNP levels from D0 to D1, lower fluid accu-
mulation on D1 and during the ICU stay, compared to the
AKI without recovery group (Figures 3Ae3F).
Predictors of better renal outcome (i.e., no AKI or
AKI with recovery)
We found that a change of < 81.8% in the delta-BNP level
from D0 to D1 could remarkably predict a better renalFigure 2 (A) Percent change in the BNP level from D0 to D1 betw
recovery group. (B) Change in the BW from D0 to D1. (C) Fluid
accumulation during the ICU stay. (F) The correlation scatter plot
accumulation on D1. * p < 0.01. AKIZ acute kidney injury; BNPZ
on ICU admission); D1 Z Day 1; D2 Z Day 2; ICU Z intensive careoutcome independently [odds ratio (OR), 17.21; pZ 0.013;
sensitivity Z 92.7%, specificity Z 80.7%]. Other predictors
included a WBC from 8954/mL to 27,663/mL (OR, 9.88;
pZ 0.001), hemoglobin level (Hb) of  12.2 g/dL (OR, 6.53;
pZ 0.020; sensitivityZ 65.0%; specificityZ 84.6%), serum
sodium level from 118 mmol/L to 145 mmol/L (OR, 6.00;
pZ 0.047), heart rate (OR, 0.96; pZ 0.013), and APACHE II
score (OR, 0.88; pZ 0.007; Table 2). Traditional fluid status
parameters such as fluid accumulation during the entire ICU
stay (pZ 0.081) was not a significant predictor of no AKI or
AKI recovery. In the final multivariate regression analysis,
these parameters yielded a predictive model with good
discriminative power. The area under the receiver oper-
ating characteristic curve was 0.896.Subgroup analysis for better renal outcome:
Interaction between fluid status parameters and
sepsis
In the subgroup analysis of patients with sepsis, we found
significant interactions between the delta-BNP levels and
sepsis and between fluid accumulation during the ICU stay
and sepsis (Table 3). In septic patients, a change in the
delta-BNP levels of > 81.8% from D0 to D1 was associated
with AKI occurrence and decreased probability of recovery
(p Z 0.003; sensitivity Z 89.5%, specificity Z 91.0%). In
nonseptic patients, greater fluid accumulation during the
ICU stay was associated with AKI occurrence and decreased
probability of recovery (p Z 0.017).een the AKI without recovery group and the no AKI or AKI with
accumulation on D1. (D) Fluid accumulation on D1. (E) Fluid
of the percent change in the BNP level from D0 to D1 and fluid
brain natriuretic peptide; BWZ body weight; D0Z Day 0 (i.e.,
unit.
Figure 3 Bar graphs of septic patients in the no AKI group and in the AKI with recovery or AKI without recovery group. (A) The BNP
level on D0. (B) The BNP level on D1. (C) The BNP level on D2. (D) The percent change in the BNP level from D0 to D1. (E) The fluid
accumulation on D1. (F) The fluid accumulation during the entire ICU stay. * p < 0.05. ** p < 0.01. BNPZ brain natriuretic peptide;
D0 Z Day 0 (i.e., on ICU admission); D1 Z Day 1; D2 Z Day 2; ICU Z intensive care unit.
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Delta-BNP levels from D0 to D1 (p Z 0.004) were inde-
pendently associated with ICU mortality (Table 4). Other
predictors included malignancy (p Z 0.030), age  58
years (p Z 0.012, sensitivity Z 69.0%,
specificity Z 84.3%), mean blood pressure < 70 mmHg or
 113 mmHg (p Z 0.040), SOFA score (p Z 0.002), serum
creatinine level on ICU admission (p Z 0.050), serum al-
bumin level (p < 0.001), and use of inotropic or vaso-
pressor drugs (p Z 0.015).Table 2 Multivariate analysis of the predictors of no AKI or AKI w
the stepwise variable selection method.a
Covariates Estimated regression
coefficient
Estim
error
Intercept 3.952 2.141
% Change in the BNP D01 <81.8% 2.846 1.148
8954/mL  WBC < 27663/mL 2.290 0.700
Hb  12.2 g/dL 1.877 0.807
118 mmol/L  Na < 145 mmol/L 1.792 0.904
Heart rate 0.040 0.016
APACHE II score 0.118 0.043
APACHE IIZ Acute Physiology and Chronic Health Evaluation II; BNP D0
CI Z confidence interval; Hb Z hemoglobin; Na Z serum sodium; W
a Goodness-of-fit assessment: the adjusted generalized R2 Z 0.445
characteristic (ROC) curve is 0.896 (i.e., > 0.7); and in the modified H
df Z 9, 144). These findings indicate an excellent fit.Subgroup analysis for mortality: Interaction
between fluid status parameters and sepsis
The delta-BNP levels and fluid accumulation during the ICU
stay both interacted with sepsis (Table S2). In septic pa-
tients, delta-BNP levels from D0 to D1 (pZ 0.002) and fluid
accumulation (p Z 0.043) were associated with mortality.
Discussion
Fluid resuscitation is the cornerstone of restoring hemo-
dynamic stability and renal blood flow, which prevents theith recovery by fitting multiple logistic regression models with
ated standard z p Estimated
odds ratio
95% CI
1.853 0.065 d d
2.481 0.013 17.21 1.64e177.06
3.272 0.001 9.88 2.74e44.53
2.334 0.020 6.53 1.53e37.62
0.981 0.047 6.00 1.02e38.64
2.493 0.013 0.96 0.93e0.99
2.721 0.007 0.89 0.81e0.96
1Z change of brain natriuretic peptide level from Day 0 to Day 1;
BC Z white blood cell count.
(i.e., > 0.3); the estimated area under the receiver operating
osmereLemeshow goodness-of-fit F test, pZ 0.115 (i.e., > 0.05;
Table 3 Multivariate analysis of the predictors of no AKI or AKI with recovery in the subgroup analysis of patients with sepsis.a
Covariate Estimated regression
coefficient
Estimated
standard error
z p Estimated
OR
95% CI
Intercept 8.222 2.499 3.291 0.001 d d
% Change in the BNP D01  81.8%  Sepsis 4.062 1.367 2.973 0.003 0.02 <0.01e0.25
Fluid accumulation during ICU stay  No sepsis 0.002 0.001 2.392 0.017 0.99 0.99e0.99
8954/mL  WBC < 27663/mL 2.745 0.754 3.641 <0.001 15.56 3.98e79.79
Hb  12.2 g/dL 2.182 0.866 2.524 0.012 8.87 1.89e58.41
118 mmol/L  Na < 145 mmol/L 2.032 0.953 2.132 0.033 7.63 1.22e57.02
Heart rate 0.051 0.018 2.833 0.005 0.95 0.91e0.98
APACHE II score 0.150 0.047 3.151 0.002 0.86 0.78e0.94
APACHE IIZ Acute Physiology and Chronic Health Evaluation II; BNPZ brain natriuretic peptide; CIZ confidence interval; D01Z change
of in the brain natriuretic peptide level from Day 0 to Day 1; Hb Z hemoglobin; Hb Z hemoglobin; ICU Z intensive care unit;
Na Z serum sodium; OR Z odds ratio; WBC Z white blood count.
a Goodness-of-fit assessment: adjusted generalized R2 Z 0.506 (i.e., > 0.3), the estimated area under the receiver operating char-
acteristic (ROC) curve Z 0.914 (i.e., > 0.7), and in the modified HosmereLemeshow goodness-of-fit F test, p Z 0.402 (i.e., > 0.05;
df Z 9, 144), which indicates an excellent fit.
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patients with AKI, Bouchard et al5 found that fluid overload,
defined as more than a 10% increase in body weight relative
to the baseline weight, resulted in greater mortality and
less chance of renal function recovery. Teixeira et al16
report that a more positive fluid balance was associated
with 28-day mortality among patients with AKI. In the
Finnish Acute Kidney Injury (FINNAKI) study,17 critically ill
patients with fluid overload at the initiation of renal
replacement therapy had twice the 90-day mortality,
compared to patients without fluid overload.
However, many methods to guide fluid therapy are
invasive and operator-dependent. For example, the central
venous pressure (CVP) level and continuous pulse contour
cardiac analysis catheter are widely used, although a sys-
tematic review has suggested these methods have a poor
relationship with blood volume.18,19 By contrast, the sono-
graphically obtained ratio of the inferior vena cava to aortaTable 4 Multivariate analysis of the predictors of intensive care
the stepwise variable selection method.a
Covariates Estimated regression
coefficient
Intercept 1.367
Malignancy 2.370
Age  58 y 1.823
MBP < 70 mmHg or  113 mmHg 1.149
SOFA score 0.335
Serum creatinine level on ICU admission
(mg/dL)
0.250
Change in the BNP D01 0.001
Serum albumin level (g/dL) 1.643
Use of inotropic or vasopressor drugs 1.779
Fluid accumulation during ICU stay (mL) 0.001
BNP Z brain natriuretic peptide; CI Z confidence interval; ICU Z int
SOFAZ SOFA, Sequential Organ Failure Assessment.
a Goodness-of-fit assessment: adjusted generalized R2 Z 0.581 (i.e
acteristic (ROC) curve is 0.909 (i.e., > 0.7); and in the modified Hos
df Z 9, 144). These findings indicate an excellent fit.diameter index seems to be useful for estimating fluid
responsiveness.20 Even so, it is operator-dependent, and
evidence of its association with outcome is rare.21 Alter-
native instruments such as bioimpedance devices estimate
extra- and intracellular fluid but these are only tested in
the static phase such as among patients on chronic dial-
ysis.22 It has not been widely studied in acutely ill patients.
In our opinion, optimal fluid status should not be
determined only by arbitrary traditional parameters or
absolute fluid volume. The optimal fluid status should be
considered physiologically. It is influenced by many factors
such as intravascular volume, vascular resistance,
myocardial compliance and contractility, and capillary
permeability.9 It is difficult to find a method that takes
these factors into account; however, BNP level has the
potential to meet these requirements. From a cardiovas-
cular standpoint, the optimal fluid status is the condition
under which the heart performs at its best.unit mortality fitting multiple logistic regression models using
Estimated
standard error
z p Estimated
OR
95% CI
1.526 0.901 0.370 d d
1.090 2.172 0.030 10.70 1.31e97.02
0.727 2.511 0.012 6.19 1.64e29.21
0.558 2.064 0.040 3.15 1.07e9.77
0.111 3.032 0.002 1.40 1.14e1.77
0.127 1.963 0.050 1.28 1.00e1.70
0.0003 2.891 0.004 1.01 1.00e1.01
0.464 3.544 < 0.001 0.19 0.07e0.46
0.734 2.422 0.015 0.17 0.04e0.69
0.0003 1.821 0.069 1.01 0.99e1.01
ensive care unit; MBP Z mean blood pressure; OR Z odds ratio;
., > 0.3, the estimated area under the receiver operating char-
mereLemeshow goodness-of-fit F test, p Z 0.3628 (i.e., > 0.05;
1194 Y.-H. Chou et al.Brain natriuretic peptide has been proven useful for
predicting the prognosis of heart failure,23 and the addition
of N-terminal pro-B-type natriuretic peptide (NT-proBNP)-
guided therapy improves clinical outcomes in patients with
heart failure.24 Furthermore, BNP may be used to predict
mortality and to guide fluid management in hemodialysis
patients.25,26
In our study, we chose BNP because of its short half-life
and relative independence from the glomerular filtration
rate and patient’s age, compared to NT pro-BNP.27,28 de Cal
et al29 report that increased BNP levels are associated with
AKI development on ICU admission or during the ICU stay.
Our patients with AKI without recovery also had signifi-
cantly higher BNP levels on D1 and D2. In addition, other
traditional, noninvasive fluid status parameters such as
change in the body weight and fluid accumulation were also
higher in the group with poor renal outcomes (Figure 2).
However, delta-BNP levels from D0 to D1 were not corre-
lated with fluid accumulation on D1. In multivariate anal-
ysis, the delta-BNP level, rather than fluid accumulation or
weight change, was significantly associated with renal
outcome and mortality. This finding indicates that the
delta-BNP level is a better predictor than the absolute BNP
level or traditional fluid status parameters, which were
significant predictors in other studies. We suggest two main
reasons for the association between positive delta-BNP
levels and poor renal outcome. First, volume overload
resulted in BNP secretion and interstitial edema and renal
damage.7 Second, more severe renal damage induced fluid
retention and BNP production. Most importantly, we found
that the cutoff level of < 81.8% in the change in delta-BNP
levels from D0 to D1 could predict a better renal outcome
(Figure S2). Therefore, the delta-BNP level may be a useful
marker as guidance for the initial fluid resuscitation to
improve renal outcome. This hypothesis should be
confirmed by randomized studies in the future.
With regard to other predictors of the better renal
outcome in our study, patients with white blood cell counts
ranging from 8954/mL to 27,663/mL had adequate immune
responses, and their diseases were not so severe as to
induce extreme leukocytosis. This finding was compatible
with a recent study that showed a U-shaped relationship for
white blood cell count and AKI.30 A higher hemoglobin level
resulted in better outcomes because it acted as a reserve
for renal blood flow and oxygenation.31 Serum sodium
levels ranging from 118 mmol/L to 145 mmol/L predicted
better renal outcomes, compared to sodium levels outside
this range. Many studies demonstrate that severe hypo- and
hypernatremia represent inadequate fluid status and are
independent risk factors for mortality.32,33 Additional fac-
tors associated with poor renal outcome included higher
APACHE II scores and higher heart rate, which indicated
severe disease.
In septic patients, an elevated BNP level is a proven
predictor of mortality.11,12 Septic patients with poor renal
outcomes also had elevated BNP levels at the beginning of
their ICU stay (Figure 3). Because volume resuscitation is an
important treatment for sepsis, the International Surviving
Sepsis Campaign Guidelines Committee recommends fluid
management to achieve a target CVP level.34 However, the
CVP level was not a predictor for outcomes in our study and
had a poor relationship with volume status andhemodynamic response.18 As a result, we performed a
subgroup analysis and determined that delta-BNP levels
from D0 to D1 remained a significant predictor of renal
outcome among our septic patients. These results could
stimulate more investigations into the application of the
BNP level in the fluid management of septic patients.
Regarding the risk factors of mortality, in contrast to
other studies in which BNP level at ICU admission was an
independent prognostic marker,35 we found that a change
in the delta-BNP levels from D0 to D1 resulted in higher risk
of death. Fluid accumulation was associated with mortality
in one report5; however, the change in delta-BNP levels
from D0 to D1 was a better predictor of mortality than fluid
accumulation. Furthermore, in our analysis and in other
studies, cancer patients had a higher mortality.36 In addi-
tion, old age has long been associated with mortality.37
Similar to other studies, a lower serum albumin level is
also a prognostic marker of death.38 Use of inotropic or
vasopressor agents has traditionally been regarded as a risk
factor of death.39 However, it was interesting that the use
of inotropic or vasopressor drugs was a beneficial predictor
in our study. This finding may be because our patients
without inotropic or vasopressor agent usage had more se-
vere disease such as respiratory failure. Even if they did not
use inotropes, they had a greater average severity score.
With regard to other predictors, a lower mean blood
pressure is a prognostic factor of mortality.40 Higher blood
pressure can also have negative consequences on the heart
and kidneys and is associated with mortality.41 In the sub-
group analysis, delta-BNP levels from D0 to D1 remained a
useful predictor of mortality in septic patients.
This prospective observational study had several limi-
tations. First, the intensive care specialists determined the
fluid management methods and the hemodynamic moni-
toring devices; therefore, not all patients had CVP data or
information from invasively placed catheters. Second, the
BNP level was checked only within the first 48 hours of the
patients’ ICU stay, and trends in BNP levels after the ICU
stay could also be associated with patient outcomes. Third,
patients with heart dysfunction were excluded in our study.
However, under usual conditions, some patients admitted
to the ICU had heart failure or acute coronary syndrome.
Whether our results could be applied in these patients re-
mains to be further evaluated.
In conclusion, a useful marker for renal outcome pre-
diction and fluid management is a major issue in critical
care. Our results demonstrated that the delta-BNP level
rather than the absolute BNP levels or other traditional
parameters was more capable in predicting outcomes in
critically ill patients. delta-Brain natriuretic peptide levels
of < 81.8% within 24 hours of ICU admission could inde-
pendently predict a better renal outcome. Even in septic
patients, the delta-BNP level remained a valuable predictor
of renal outcome. The BNP level may be a biomarker for
monitoring and helping to achieve optimal fluid status in
critically ill patients.Acknowledgments
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